Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Infectious Vaccines market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Infectious Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Infectious Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline plc (UK)
MedImmune LLC (US)
Johnson and Johnson (US)
Emergent Bio Solutions Inc (US)
Sanofi Pasteur (France)
CSL Limited (Australia)
Bavarian Nordic (Denmark)
Pfizer Inc (US)
Merck and Company (US)
Novartis AG (Switzerland)
By Type:
Preventive vaccine
Therapeutic vaccine
By End-User:
Adults
Pediatrics
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Infectious Vaccines Market
-
1.3 Market Segment by Type
-
1.3.1 China Infectious Vaccines Market Size and Growth Rate of Preventive vaccine from 2016 to 2027
-
1.3.2 China Infectious Vaccines Market Size and Growth Rate of Therapeutic vaccine from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Infectious Vaccines Market Size and Growth Rate of Adults from 2016 to 2027
-
1.4.2 China Infectious Vaccines Market Size and Growth Rate of Pediatrics from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Infectious Vaccines Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Infectious Vaccines by Major Types
-
3.4.1 Market Size and Growth Rate of Preventive vaccine
-
3.4.2 Market Size and Growth Rate of Therapeutic vaccine
4 Segmentation of Infectious Vaccines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Infectious Vaccines by Major End-Users
-
4.4.1 Market Size and Growth Rate of Infectious Vaccines in Adults
-
4.4.2 Market Size and Growth Rate of Infectious Vaccines in Pediatrics
5 Market Analysis by Regions
-
5.1 China Infectious Vaccines Production Analysis by Regions
-
5.2 China Infectious Vaccines Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Infectious Vaccines Landscape Analysis
-
6.1 North China Infectious Vaccines Landscape Analysis by Major Types
-
6.2 North China Infectious Vaccines Landscape Analysis by Major End-Users
7 Central China Infectious Vaccines Landscape Analysis
-
7.1 Central China Infectious Vaccines Landscape Analysis by Major Types
-
7.2 Central China Infectious Vaccines Landscape Analysis by Major End-Users
8 South China Infectious Vaccines Landscape Analysis
-
8.1 South China Infectious Vaccines Landscape Analysis by Major Types
-
8.2 South China Infectious Vaccines Landscape Analysis by Major End-Users
9 East China Infectious Vaccines Landscape Analysis
-
9.1 East China Infectious Vaccines Landscape Analysis by Major Types
-
9.2 East China Infectious Vaccines Landscape Analysis by Major End-Users
10 Northeast China Infectious Vaccines Landscape Analysis
-
10.1 Northeast China Infectious Vaccines Landscape Analysis by Major Types
-
10.2 Northeast China Infectious Vaccines Landscape Analysis by Major End-Users
11 Southwest China Infectious Vaccines Landscape Analysis
-
11.1 Southwest China Infectious Vaccines Landscape Analysis by Major Types
-
11.2 Southwest China Infectious Vaccines Landscape Analysis by Major End-Users
12 Northwest China Infectious Vaccines Landscape Analysis
-
12.1 Northwest China Infectious Vaccines Landscape Analysis by Major Types
-
12.2 Northwest China Infectious Vaccines Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 GlaxoSmithKline plc (UK)
-
13.1.1 GlaxoSmithKline plc (UK) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 MedImmune LLC (US)
-
13.2.1 MedImmune LLC (US) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Johnson and Johnson (US)
-
13.3.1 Johnson and Johnson (US) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Emergent Bio Solutions Inc (US)
-
13.4.1 Emergent Bio Solutions Inc (US) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Sanofi Pasteur (France)
-
13.5.1 Sanofi Pasteur (France) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 CSL Limited (Australia)
-
13.6.1 CSL Limited (Australia) Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bavarian Nordic (Denmark)
-
13.7.1 Bavarian Nordic (Denmark) Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Pfizer Inc (US)
-
13.8.1 Pfizer Inc (US) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Merck and Company (US)
-
13.9.1 Merck and Company (US) Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Novartis AG (Switzerland)
-
13.10.1 Novartis AG (Switzerland) Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Infectious Vaccines Market Size and Growth Rate of Preventive vaccine from 2016 to 2027
-
Figure China Infectious Vaccines Market Size and Growth Rate of Therapeutic vaccine from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Infectious Vaccines Market Size and Growth Rate of Adults from 2016 to 2027
-
Figure China Infectious Vaccines Market Size and Growth Rate of Pediatrics from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Infectious Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Infectious Vaccines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Infectious Vaccines
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Infectious Vaccines by Different Types from 2016 to 2027
-
Table Consumption Share of Infectious Vaccines by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Preventive vaccine
-
Figure Market Size and Growth Rate of Therapeutic vaccine
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Infectious Vaccines by Different End-Users from 2016 to 2027
-
Table Consumption Share of Infectious Vaccines by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Adults
-
Figure Market Size and Growth Rate of Pediatrics
-
Table China Infectious Vaccines Production by Regions
-
Table China Infectious Vaccines Production Share by Regions
-
Figure China Infectious Vaccines Production Share by Regions in 2016
-
Figure China Infectious Vaccines Production Share by Regions in 2021
-
Figure China Infectious Vaccines Production Share by Regions in 2027
-
Table China Infectious Vaccines Consumption by Regions
-
Table China Infectious Vaccines Consumption Share by Regions
-
Figure China Infectious Vaccines Consumption Share by Regions in 2016
-
Figure China Infectious Vaccines Consumption Share by Regions in 2021
-
Figure China Infectious Vaccines Consumption Share by Regions in 2027
-
Table North China Infectious Vaccines Consumption by Types from 2016 to 2027
-
Table North China Infectious Vaccines Consumption Share by Types from 2016 to 2027
-
Figure North China Infectious Vaccines Consumption Share by Types in 2016
-
Figure North China Infectious Vaccines Consumption Share by Types in 2021
-
Figure North China Infectious Vaccines Consumption Share by Types in 2027
-
Table North China Infectious Vaccines Consumption by End-Users from 2016 to 2027
-
Table North China Infectious Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure North China Infectious Vaccines Consumption Share by End-Users in 2016
-
Figure North China Infectious Vaccines Consumption Share by End-Users in 2021
-
Figure North China Infectious Vaccines Consumption Share by End-Users in 2027
-
Table Central China Infectious Vaccines Consumption by Types from 2016 to 2027
-
Table Central China Infectious Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Central China Infectious Vaccines Consumption Share by Types in 2016
-
Figure Central China Infectious Vaccines Consumption Share by Types in 2021
-
Figure Central China Infectious Vaccines Consumption Share by Types in 2027
-
Table Central China Infectious Vaccines Consumption by End-Users from 2016 to 2027
-
Table Central China Infectious Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Infectious Vaccines Consumption Share by End-Users in 2016
-
Figure Central China Infectious Vaccines Consumption Share by End-Users in 2021
-
Figure Central China Infectious Vaccines Consumption Share by End-Users in 2027
-
Table South China Infectious Vaccines Consumption by Types from 2016 to 2027
-
Table South China Infectious Vaccines Consumption Share by Types from 2016 to 2027
-
Figure South China Infectious Vaccines Consumption Share by Types in 2016
-
Figure South China Infectious Vaccines Consumption Share by Types in 2021
-
Figure South China Infectious Vaccines Consumption Share by Types in 2027
-
Table South China Infectious Vaccines Consumption by End-Users from 2016 to 2027
-
Table South China Infectious Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure South China Infectious Vaccines Consumption Share by End-Users in 2016
-
Figure South China Infectious Vaccines Consumption Share by End-Users in 2021
-
Figure South China Infectious Vaccines Consumption Share by End-Users in 2027
-
Table East China Infectious Vaccines Consumption by Types from 2016 to 2027
-
Table East China Infectious Vaccines Consumption Share by Types from 2016 to 2027
-
Figure East China Infectious Vaccines Consumption Share by Types in 2016
-
Figure East China Infectious Vaccines Consumption Share by Types in 2021
-
Figure East China Infectious Vaccines Consumption Share by Types in 2027
-
Table East China Infectious Vaccines Consumption by End-Users from 2016 to 2027
-
Table East China Infectious Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure East China Infectious Vaccines Consumption Share by End-Users in 2016
-
Figure East China Infectious Vaccines Consumption Share by End-Users in 2021
-
Figure East China Infectious Vaccines Consumption Share by End-Users in 2027
-
Table Northeast China Infectious Vaccines Consumption by Types from 2016 to 2027
-
Table Northeast China Infectious Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Infectious Vaccines Consumption Share by Types in 2016
-
Figure Northeast China Infectious Vaccines Consumption Share by Types in 2021
-
Figure Northeast China Infectious Vaccines Consumption Share by Types in 2027
-
Table Northeast China Infectious Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northeast China Infectious Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Infectious Vaccines Consumption Share by End-Users in 2016
-
Figure Northeast China Infectious Vaccines Consumption Share by End-Users in 2021
-
Figure Northeast China Infectious Vaccines Consumption Share by End-Users in 2027
-
Table Southwest China Infectious Vaccines Consumption by Types from 2016 to 2027
-
Table Southwest China Infectious Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Infectious Vaccines Consumption Share by Types in 2016
-
Figure Southwest China Infectious Vaccines Consumption Share by Types in 2021
-
Figure Southwest China Infectious Vaccines Consumption Share by Types in 2027
-
Table Southwest China Infectious Vaccines Consumption by End-Users from 2016 to 2027
-
Table Southwest China Infectious Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Infectious Vaccines Consumption Share by End-Users in 2016
-
Figure Southwest China Infectious Vaccines Consumption Share by End-Users in 2021
-
Figure Southwest China Infectious Vaccines Consumption Share by End-Users in 2027
-
Table Northwest China Infectious Vaccines Consumption by Types from 2016 to 2027
-
Table Northwest China Infectious Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Infectious Vaccines Consumption Share by Types in 2016
-
Figure Northwest China Infectious Vaccines Consumption Share by Types in 2021
-
Figure Northwest China Infectious Vaccines Consumption Share by Types in 2027
-
Table Northwest China Infectious Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northwest China Infectious Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Infectious Vaccines Consumption Share by End-Users in 2016
-
Figure Northwest China Infectious Vaccines Consumption Share by End-Users in 2021
-
Figure Northwest China Infectious Vaccines Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline plc (UK)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc (UK)
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc (UK)
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc (UK)
-
Table Product and Service Introduction of GlaxoSmithKline plc (UK)
-
Table Company Profile and Development Status of MedImmune LLC (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune LLC (US)
-
Figure Sales and Growth Rate Analysis of MedImmune LLC (US)
-
Figure Revenue and Market Share Analysis of MedImmune LLC (US)
-
Table Product and Service Introduction of MedImmune LLC (US)
-
Table Company Profile and Development Status of Johnson and Johnson (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson (US)
-
Figure Sales and Growth Rate Analysis of Johnson and Johnson (US)
-
Figure Revenue and Market Share Analysis of Johnson and Johnson (US)
-
Table Product and Service Introduction of Johnson and Johnson (US)
-
Table Company Profile and Development Status of Emergent Bio Solutions Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent Bio Solutions Inc (US)
-
Figure Sales and Growth Rate Analysis of Emergent Bio Solutions Inc (US)
-
Figure Revenue and Market Share Analysis of Emergent Bio Solutions Inc (US)
-
Table Product and Service Introduction of Emergent Bio Solutions Inc (US)
-
Table Company Profile and Development Status of Sanofi Pasteur (France)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur (France)
-
Figure Sales and Growth Rate Analysis of Sanofi Pasteur (France)
-
Figure Revenue and Market Share Analysis of Sanofi Pasteur (France)
-
Table Product and Service Introduction of Sanofi Pasteur (France)
-
Table Company Profile and Development Status of CSL Limited (Australia)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited (Australia)
-
Figure Sales and Growth Rate Analysis of CSL Limited (Australia)
-
Figure Revenue and Market Share Analysis of CSL Limited (Australia)
-
Table Product and Service Introduction of CSL Limited (Australia)
-
Table Company Profile and Development Status of Bavarian Nordic (Denmark)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordic (Denmark)
-
Figure Sales and Growth Rate Analysis of Bavarian Nordic (Denmark)
-
Figure Revenue and Market Share Analysis of Bavarian Nordic (Denmark)
-
Table Product and Service Introduction of Bavarian Nordic (Denmark)
-
Table Company Profile and Development Status of Pfizer Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc (US)
-
Figure Sales and Growth Rate Analysis of Pfizer Inc (US)
-
Figure Revenue and Market Share Analysis of Pfizer Inc (US)
-
Table Product and Service Introduction of Pfizer Inc (US)
-
Table Company Profile and Development Status of Merck and Company (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck and Company (US)
-
Figure Sales and Growth Rate Analysis of Merck and Company (US)
-
Figure Revenue and Market Share Analysis of Merck and Company (US)
-
Table Product and Service Introduction of Merck and Company (US)
-
Table Company Profile and Development Status of Novartis AG (Switzerland)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)
-
Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)
-
Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)
-
Table Product and Service Introduction of Novartis AG (Switzerland)
-
